AI-generated from publicly available materials.Michael Polansky has established Outer Biosciences, a biotech firm focused on harnessing artificial intelligence to discover innovative cosmetic ingredients.
Outer Biosciences utilizes donated human skin samples to explore various skin processes, such as collagen remodeling and pigmentation. By maintaining the viability of these samples outside the human body for up to a month, the company can conduct in-depth research on skin health and recovery mechanisms. The AI technology employed by the startup predicts effective chemical compounds, which are subsequently tested on the skin tissue, with results enhancing the predictive model for future experiments.
The company currently has six active candidates and numerous other compounds under evaluation. Rather than creating its own consumer products, Outer Biosciences aims to license or sell its findings to established cosmetic and pharmaceutical companies. Founded in 2022, the startup has successfully raised approximately $23 million and has a dedicated team of 19 employees, with Lady Gaga serving on its board.
This innovative approach not only showcases the intersection of biotechnology and cosmetics but also highlights the potential for AI to revolutionize ingredient development in the beauty industry. As consumer demand for scientifically-backed products grows, Outer Biosciences could play a pivotal role in shaping the future of skincare.